Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The major pathway for the biosynthesis of phosphatidylcholine occurs via the CDP-choline pathway. Additionally we are shipping Choline Kinase alpha Proteins (9) and Choline Kinase alpha Kits (8) and many more products for this protein.
Showing 10 out of 59 products:
Human Polyclonal Choline Kinase alpha Primary Antibody for ELISA, WB - ABIN560360
Vanpouille, Le Jeune, Kryza, Clotagatide, Janier, Dubois, Perek: Influence of multidrug resistance on (18)F-FCH cellular uptake in a glioblastoma model. in European journal of nuclear medicine and molecular imaging 2009
Human Polyclonal Choline Kinase alpha Primary Antibody for WB - ABIN392815
Zhang, Chen, Yang, Li, Bao, Wu, Jiang: CHKA mediates the poor prognosis of lung adenocarcinoma and acts as a prognostic indicator. in Oncology letters 2016
miR (show MLXIP Antibodies)-876-5p was able to significantly decrease the expression level of choline kinase alpha mRNA.
There is no correlation between single CHKA rs7928739 polymorphism and the incidence of intrauterine fetal death.
This study presents the detail the 2.35 A structure of choline kinase alpha in complex with inhibitor TCD (show CHM Antibodies)-717.
Results indicate that choline kinase alpha (CHKA) contributes to tumor progression and metastasis and may serve as a prognostic biomarker and potential therapeutic target in colorectal carcinoma (CRC (show CALR Antibodies)).
We found levels of CHKA to be increased in human HCCs (show HCCS Antibodies) compared to nontumor tissues, and increased expression to be associated with tumor aggressiveness. Overexpression of CHKA in HCC (show FAM126A Antibodies) cell lines increased their invasiveness, resistance to EGFR (show EGFR Antibodies) inhibitors, and ability to form metastatic tumors in mice by promoting interaction of EGFR (show EGFR Antibodies) with mechanistic target of rapamycin (show FRAP1 Antibodies) complex 2.
Study shows increased CHKA expression in pancreatic ductal adenocarcinoma tumors and may be a predictive marker of response to chemotherapy.
These data also support the approach of antitumor strategies that destabilize Chk-alpha protein or downregulate PtdCho in breast cancer treatment.
Downregulation of choline kinase-alpha enhances autophagy in tamoxifen-resistant breast cancer cells.
CHKA can act as an AR chaperone, providing, to our knowledge, the first evidence for kinases as molecular chaperones, making CHKA both a marker of tumor progression and a potential therapeutic target for PCa (show FLVCR1 Antibodies).
Identify choline kinase alpha as a key regulator of glutathione-dependent antioxidant cell defense in ovarian carcinoma.
hepatic phosphatidylcholine (show SGMS2 Antibodies) is regulated by the circadian clock through a Bmal1 (show ARNTL Antibodies)-Rev-erbalpha (show NR1D1 Antibodies)-Chkalpha axis
Enforced expression of either CK(alpha) or CCTalpha (show PCYT1A Antibodies) increased the rate of synthesis and the amount of PtdCho, and these cells initiated neuronal differentiation.
Lack of muscle degeneration in forelimbs of Chkb (show CHKB Antibodies)(-/-) mice is due to abundant choline kinase alpha and the stable homeostasis of phosphatidylcholine (show SGMS2 Antibodies).
Experimental evidence for the presence of heteromeric ChoK/EtnK in any source. The activity of ChoK/EtnK in the cell is controlled not only by the level of each isoform but also by their combination to form the active oligomer complex.
ChoK may have a role in carcinogenesis
Data suggest that the choline kinase alpha promoter has a distal element (-875/-867) that binds c-jun (show JUN Antibodies) and the binding of c-jun (show JUN Antibodies) is enhanced by treatment with CCl4 (show CCL4 Antibodies).
Chka is an essential gene for early embryonic development, but adult mice do not require full expression of the gene for normal levels of phosphatidylcholine (show SGMS2 Antibodies).
The major pathway for the biosynthesis of phosphatidylcholine occurs via the CDP-choline pathway. The protein encoded by this gene is the initial enzyme in the sequence and may play a regulatory role. The encoded protein also catalyzes the phosphorylation of ethanolamine. Two transcript variants encoding different isoforms have been found for this gene.
choline kinase alpha
, choline kinase beta
, choline kinase
, ethanolamine kinase
, choline/ethanolamine kinase alpha
, choline kinase R